genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Cell biology

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies
GEN Edge

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism
Drug Discovery

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show
Cancer

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show

New Spatial Company, Moleculent, Focuses on Mapping Communication Between Cells
News

New Spatial Company, Moleculent, Focuses on Mapping Communication Between Cells

Lifespan in Mice Shortens with Increase in Nutrient Signaling to mTOR
News

Lifespan in Mice Shortens with Increase in Nutrient Signaling to mTOR

Antioxidant Gel Preserves Function of Pancreatic Islets Transplanted into Intestinal Fat Layer in Preclinical Study
Featured

Antioxidant Gel Preserves Function of Pancreatic Islets Transplanted into Intestinal Fat Layer in Preclinical Study

Noncoding Gene Identified as Cause of Intellectual Disability Affecting Thousands
Featured

Noncoding Gene Identified as Cause of Intellectual Disability Affecting Thousands

Adding Metabolism to Models of Bioprocessing
Bioprocessing

Adding Metabolism to Models of Bioprocessing

Cannibalism Genes in Human Genome Evolved to Serve New Cellular Functions
Cancer

Cannibalism Genes in Human Genome Evolved to Serve New Cellular Functions

Severe COVID-19 Lung Disease Linked to Ferroptosis
Infectious Diseases

Severe COVID-19 Lung Disease Linked to Ferroptosis

123...238Page 1 of 238

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up